Influence of age on the occurrence of adverse events in rheumatic patients at the onset of biological treatment: data from the BIOBADASER III register.

Arthritis Research & Therapy
Paloma VelaJuan Jesús Gómez-Reino

Abstract

To assess whether age, at the beginning of biologic treatment, is associated with the time a first adverse event (AE) appears in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS), or psoriatic arthritis (PsA). All patients in the BIOBADASER registry diagnosed with RA, AS, and PsA, and classified as young (< 25 years old), adult (25-64 years old), elderly (65-75 years old) or very elderly (> 75 years old) at start of biological treatment were included. Factors associated with the appearance of a first AE using adjusted incidence rate ratios (IRR) (Poisson regression) were analyzed. Survival to first AE was studied by Kaplan-Meier analysis and hazard ratios (HR) by Cox regression. 2483 patients were included: 1126 RA, 680 PsA, and 677 AS. Age group stratification was as follows: 63 young, 2127 adults, 237 elderly, and 56 very elderly. Regression model revealed an increased probability of suffering a first AE at age 65 years or older [IRR elderly: 1.42 (CI95% 1.13-1.77)]. Other characteristics associated with AE were female gender, the use of DMARDs, including methotrexate, the presence of comorbidities, and the time of disease duration. Factors that had the greatest impact on survival over a first AE were age >...Continue Reading

References

Jan 20, 1998·Arthritis and Rheumatism·J BraunJ Sieper
Sep 16, 2000·Rheumatic Diseases Clinics of North America·Y Yazici, S A Paget
Mar 21, 2007·Rheumatic Diseases Clinics of North America·Veena K Ranganath, Daniel E Furst
May 2, 2007·Arthritis and Rheumatism·Stéphane GenevayUNKNOWN Physicians of the Swiss Clinical Quality Management Program for Rheumatoid Arthritis
Nov 19, 2008·Annals of the Rheumatic Diseases·B J RadovitsR F J M Laan
Nov 26, 2010·Clinics in Geriatric Medicine·Qian-Li Xue
Mar 17, 2012·The Journal of Rheumatology·Carlos MontillaUNKNOWN REGISPONSER Study Group
Jul 27, 2012·Arthritis Care & Research·Jessica WiddifieldClaire Bombardier
Dec 6, 2012·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Morgan E Levine
Apr 11, 2014·International Journal of Rheumatic Diseases·Nozomi IwanagaTomoki Origuchi
Jan 13, 2015·Pharmacy Practice·Shamsher Singh, Beata Bajorek
May 3, 2016·International Journal of Rheumatic Diseases·Teck C TanUNKNOWN TTSH Rheumatoid Arthritis Study Group
Feb 17, 2017·International Journal of Rheumatic Diseases·Eri KatoShigeto Tohma
Apr 20, 2017·Current Opinion in Rheumatology·Fabiola AtzeniPiercarlo Sarzi-Puttini
Sep 25, 2017·Reumatología clinica·Carlos Sanchez-PiedraUNKNOWN en representación del Grupo de trabajo BIOBADASER Fase III
Nov 12, 2018·International Journal of Rheumatic Diseases·Koichi MurataShuichi Matsuda

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Software Mentioned

Stata
BIOBADASER

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Allergy, Asthma & Immunology Research
Ji Hyun LeeSang Hyun Cho
Reumatología clinica
Miguel Ángel DescalzoGrupo de Estudio BIOBADASER
© 2022 Meta ULC. All rights reserved